Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 8.64 Delayed Data As of 3:59pm ET |  +0.15 / +1.77%Today’s Change | 5.81 Today|||52-Week Range 33.79 | -2.37% Year-to-Date |
Latest INO News | Press Releases
| Should You Buy Biotech ETFs Now? Jun 16 / Zacks.com - Paid Partner Content | Why Inovio Stock Is Sinking Today Jun 10 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 8.49 |
| Today’s open | 8.50 |
| Day’s range | 8.41 - 8.76 |
| Volume | 163,303 |
| Average volume (3 months) | 9,609,780 |
| Market cap | $1.8B |
Data as of 3:59pm ET, 06/21/2021
Growth & Valuation
| Earnings growth (last year) | +11.28% |
| Earnings growth (this year) | +13.08% |
| Earnings growth (next 5 years) | +45.81% |
| Revenue growth (last year) | +80.24% |
| P/E ratio | NM |
| Price/Sales | 185.24 |
| Price/Book | 3.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZYMEZymeworks Inc | +0.50 | +1.38% |
| ZEALZealand Pharma A/S | 0.00 | 0.00% |
| ---- | ||
| YMABY-mAbs Therapeutics ... | +0.60 | +1.66% |
Data as of 4:00pm ET, 06/21/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.25 |
| Annual revenue (last year) | $7.4M |
| Annual profit (last year) | -$166.4M |
| Net profit margin | -2,245.39% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
